|
VCP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.36199948489002E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75759999998526E-07 |
| Normal-vs-Stage2 |
1.32880000003333E-06 |
| Normal-vs-Stage3 |
3.61789487257624E-11 |
| Normal-vs-Stage4 |
2.428000E-04 |
| Stage1-vs-Stage2 |
1.475430E-01 |
| Stage1-vs-Stage3 |
3.099700E-03 |
| Stage1-vs-Stage4 |
5.840000E-01 |
| Stage2-vs-Stage3 |
4.771800E-01 |
| Stage2-vs-Stage4 |
5.594000E-01 |
| Stage3-vs-Stage4 |
1.935390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.2598001248042E-10 |
| Normal-vs-AfricanAmerican |
1.020750E-04 |
| Normal-vs-Asian |
8.800300E-02 |
| Caucasian-vs-AfricanAmerican |
7.976200E-01 |
| Caucasian-vs-Asian |
6.351400E-01 |
| AfricanAmerican-vs-Asian |
7.126000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22777352121284E-12 |
| Normal-vs-Female |
1.038730E-04 |
| Male-vs-Female |
7.364100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.326080E-02 |
| Normal-vs-Age(41-60Yrs) |
1.91439999963627E-07 |
| Normal-vs-Age(61-80Yrs) |
1.48209999828453E-10 |
| Normal-vs-Age(81-100Yrs) |
4.826100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.166800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.740800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.839400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.354440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.220410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.167000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.255800E-01 |
| Normal-vs-Grade 2 |
1.67359999969641E-07 |
| Normal-vs-Grade 3 |
1.17799991983247E-10 |
| Normal-vs-Grade 4 |
2.76590000003463E-06 |
| Grade 1-vs-Grade 2 |
1.064240E-01 |
| Grade 1-vs-Grade 3 |
3.348000E-02 |
| Grade 1-vs-Grade 4 |
6.949700E-02 |
| Grade 2-vs-Grade 3 |
4.903600E-02 |
| Grade 2-vs-Grade 4 |
1.803200E-01 |
| Grade 3-vs-Grade 4 |
9.091000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.24879999999317E-06 |
| Normal-vs-ccB subtype |
1.06709996394727E-09 |
| ccA subtype-vs-ccB subtype |
4.891800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.96950000542051E-09 |
| Normal-vs-N1 |
2.423000E-01 |
| N0-vs-N1 |
4.177800E-01 |
|
|
